Standard

Implementation of back at work after surgery (BAAS) : A feasibility study of an integrated pathway for improved return to work after knee arthroplasty. / Strijbos, Daniël O; van der Sluis, Geert; Boymans, Tim A E J; de Groot, Stephan; Klomp, Simon; Kooijman, Carolien M; Reneman, Michiel F; Kuijer, P Paul F M.

In: Musculoskeletal care, 04.05.2022.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

APA

Strijbos, D. O., van der Sluis, G., Boymans, T. A. E. J., de Groot, S., Klomp, S., Kooijman, C. M., Reneman, M. F., & Kuijer, P. P. F. M. (2022). Implementation of back at work after surgery (BAAS): A feasibility study of an integrated pathway for improved return to work after knee arthroplasty. Musculoskeletal care. https://doi.org/10.1002/msc.1633

Vancouver

Author

Strijbos, Daniël O ; van der Sluis, Geert ; Boymans, Tim A E J ; de Groot, Stephan ; Klomp, Simon ; Kooijman, Carolien M ; Reneman, Michiel F ; Kuijer, P Paul F M. / Implementation of back at work after surgery (BAAS) : A feasibility study of an integrated pathway for improved return to work after knee arthroplasty. In: Musculoskeletal care. 2022.

BibTeX

@article{43f1c01c99d64c1a8f4cf42ef5b4b458,
title = "Implementation of back at work after surgery (BAAS): A feasibility study of an integrated pathway for improved return to work after knee arthroplasty",
abstract = "PURPOSE: Optimizing return to work after knee arthroplasty is becoming more important because of the growing incidence of KA among workers and poor return to work outcomes. The purpose of this study is to investigate the feasibility of Back At work After Surgery (BAAS): an integrated clinical pathway for return to work after knee arthroplasty.METHOD: Working patients who received unicompartmental knee arthroplasty (UKA) or total knee arthroplasty (TKA) between January 2021 and November 2021, younger than 65 years and motivated to return to work were eligible to participate. Feasibility was investigated on five domains: reach, dose delivered, dose received, fidelity and patients' attitudes. These outcomes were obtained by a patient-reported questionnaire and an interview with the occupational case manager and medical case manager.RESULTS: Of the eligible 29 patients, eleven were willing to participate (response rate 38%; due to travel distance to and from the hospital). The dose delivered was between 91 and 100%, except information given about return to work from the orthopedic surgeon which was 18%. The dose received was 100%. For fidelity, case managers reported nine shortcomings for which five solutions were mentioned. In terms of patients' attitude, all patients were satisfied and one patient mentioned an improvement.CONCLUSIONS: In terms of reach, participation was low: only 29%. The BAAS clinical pathway seems feasible based on dose delivered, dose received, fidelity and patient attitudes. The next step is to assess the effectiveness of the BAAS clinical pathway for return to work.",
keywords = "feasibility studies, health plan implementation, knee arthroplasty, occupational health service, orthopedics, physical therapy modalities, return to work",
author = "Strijbos, {Dani{\"e}l O} and {van der Sluis}, Geert and Boymans, {Tim A E J} and {de Groot}, Stephan and Simon Klomp and Kooijman, {Carolien M} and Reneman, {Michiel F} and Kuijer, {P Paul F M}",
note = "Funding Information: Special thanks to Bert Schmaal for making this work possible and the patients who participated in the feasibility study. This project was made possible by funding from a.s.r. Insurances. Publisher Copyright: {\textcopyright} 2022 The Authors. Musculoskeletal Care published by John Wiley & Sons Ltd.",
year = "2022",
month = may,
day = "4",
doi = "10.1002/msc.1633",
language = "English",
journal = "Musculoskeletal care",
issn = "1478-2189",
publisher = "Wiley-Blackwell",

}

RIS

TY - JOUR

T1 - Implementation of back at work after surgery (BAAS)

T2 - A feasibility study of an integrated pathway for improved return to work after knee arthroplasty

AU - Strijbos, Daniël O

AU - van der Sluis, Geert

AU - Boymans, Tim A E J

AU - de Groot, Stephan

AU - Klomp, Simon

AU - Kooijman, Carolien M

AU - Reneman, Michiel F

AU - Kuijer, P Paul F M

N1 - Funding Information: Special thanks to Bert Schmaal for making this work possible and the patients who participated in the feasibility study. This project was made possible by funding from a.s.r. Insurances. Publisher Copyright: © 2022 The Authors. Musculoskeletal Care published by John Wiley & Sons Ltd.

PY - 2022/5/4

Y1 - 2022/5/4

N2 - PURPOSE: Optimizing return to work after knee arthroplasty is becoming more important because of the growing incidence of KA among workers and poor return to work outcomes. The purpose of this study is to investigate the feasibility of Back At work After Surgery (BAAS): an integrated clinical pathway for return to work after knee arthroplasty.METHOD: Working patients who received unicompartmental knee arthroplasty (UKA) or total knee arthroplasty (TKA) between January 2021 and November 2021, younger than 65 years and motivated to return to work were eligible to participate. Feasibility was investigated on five domains: reach, dose delivered, dose received, fidelity and patients' attitudes. These outcomes were obtained by a patient-reported questionnaire and an interview with the occupational case manager and medical case manager.RESULTS: Of the eligible 29 patients, eleven were willing to participate (response rate 38%; due to travel distance to and from the hospital). The dose delivered was between 91 and 100%, except information given about return to work from the orthopedic surgeon which was 18%. The dose received was 100%. For fidelity, case managers reported nine shortcomings for which five solutions were mentioned. In terms of patients' attitude, all patients were satisfied and one patient mentioned an improvement.CONCLUSIONS: In terms of reach, participation was low: only 29%. The BAAS clinical pathway seems feasible based on dose delivered, dose received, fidelity and patient attitudes. The next step is to assess the effectiveness of the BAAS clinical pathway for return to work.

AB - PURPOSE: Optimizing return to work after knee arthroplasty is becoming more important because of the growing incidence of KA among workers and poor return to work outcomes. The purpose of this study is to investigate the feasibility of Back At work After Surgery (BAAS): an integrated clinical pathway for return to work after knee arthroplasty.METHOD: Working patients who received unicompartmental knee arthroplasty (UKA) or total knee arthroplasty (TKA) between January 2021 and November 2021, younger than 65 years and motivated to return to work were eligible to participate. Feasibility was investigated on five domains: reach, dose delivered, dose received, fidelity and patients' attitudes. These outcomes were obtained by a patient-reported questionnaire and an interview with the occupational case manager and medical case manager.RESULTS: Of the eligible 29 patients, eleven were willing to participate (response rate 38%; due to travel distance to and from the hospital). The dose delivered was between 91 and 100%, except information given about return to work from the orthopedic surgeon which was 18%. The dose received was 100%. For fidelity, case managers reported nine shortcomings for which five solutions were mentioned. In terms of patients' attitude, all patients were satisfied and one patient mentioned an improvement.CONCLUSIONS: In terms of reach, participation was low: only 29%. The BAAS clinical pathway seems feasible based on dose delivered, dose received, fidelity and patient attitudes. The next step is to assess the effectiveness of the BAAS clinical pathway for return to work.

KW - feasibility studies

KW - health plan implementation

KW - knee arthroplasty

KW - occupational health service

KW - orthopedics

KW - physical therapy modalities

KW - return to work

UR - http://www.scopus.com/inward/record.url?scp=85129278725&partnerID=8YFLogxK

U2 - 10.1002/msc.1633

DO - 10.1002/msc.1633

M3 - Article

C2 - 35506461

JO - Musculoskeletal care

JF - Musculoskeletal care

SN - 1478-2189

ER -

ID: 23395630